The ADOPT trial (Assessment of Efficacies of Cardiac Resynchronization Therapies (CRT-P/D) for Heart Failure Patients in China): rationale, design, and end-points

Abstract

Bing Liu1* Fu Yi1* hongwei Cai2 Wenyi guo1 Weijie Li1 Min shen1 Jielai Xia3 Liwen Liu4 haichang Wang1 on behalf of The ADOPT study steering Committee and investigators 1Department of Cardiology, Xijing hospital, FMMU, Xi’an, China; 2Department of information, school of stomatology, FMMU, Xi’an, China; 3Department of statistics, FMMU, Xi’an, China; 4Department of Ultrasound, Xijing hospital, FMMU, Xi’an, China